Insider · CIK 0001851034

Finley John David

Reports to the SEC for 1 company · DENVER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001851034

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−3.06M sh	—	—	6,119,600
2026-10-06	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+3.23M sh	—	—	3,356,672
2026-10-06	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−168K sh	—	—	1,508,249
2026-10-06	PALIPALISADE BIO, INC.F Tax Payment	Director, CEO CFO	FTax Payment	−1.41M sh	$1.49	−$2.1M	1,944,690
2026-08-19	PALIPALISADE BIO, INC.G Gift	Director, CEO CFO	GGift	−88.4K sh	—	—	129,288
2026-08-19	PALIPALISADE BIO, INC.G Gift	Director, CEO CFO	GGift	+88.4K sh	—	—	88,451
2026-07-07	PALIPALISADE BIO, INC. · Series 2 Common Stock Purchase WarrantM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−133 sh	—	—	0
2026-07-07	PALIPALISADE BIO, INC.S Sale	Director, CEO CFO	SSale	−147K sh	$2.07	−$303K	217,555
2026-07-07	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+133 sh	$0.70	+$93.1	217,688
2026-07-06	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+335K sh	—	—	364,353
2026-07-06	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−335K sh	—	—	1,675,833
2026-02-12	PALIPALISADE BIO, INC.S Sale	Director, CEO CFO	SSale	−3,896 sh	$1.75	−$6,818	27,353
2026-02-11	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+13.3K sh	—	—	31,249
2026-02-11	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−13.3K sh	—	—	26,667
2026-02-09	PALIPALISADE BIO, INC. · Restricted Stock UnitsA Award	Director, CEO CFO	AAward	+2.01M sh	—	—	2,011,000
2025-10-06	PALIPALISADE BIO, INC. · Restricted Stock UnitsA Award	Director, CEO CFO	AAward	+9.18M sh	—	—	9,179,400
2025-09-04	PALIPALISADE BIO, INC. · Phantom UnitsA Award	Director, CEO CFO	AAward	+323K sh	—	—	323,400
2025-02-11	PALIPALISADE BIO, INC. · Stock Option (Right to Buy)A Award	Director, CEO CFO	AAward	+47K sh	—	—	47,000
2025-02-11	PALIPALISADE BIO, INC. · Restricted Stock UnitsA Award	Director, CEO CFO	AAward	+40K sh	—	—	40,000
2024-05-28	PALIPALISADE BIO, INC.F Tax Payment	Director, CEO CFO	FTax Payment	−467 sh	$4.76	−$2,222.92	9,592
2024-05-28	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−2,111 sh	—	—	0
2024-05-28	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+2,111 sh	—	—	14,079
2024-05-28	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+3,335 sh	—	—	12,927
2024-05-28	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+1,622 sh	—	—	10,059
2024-05-28	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−1,622 sh	—	—	0
2024-05-28	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−3,335 sh	—	—	0
2024-05-28	PALIPALISADE BIO, INC.F Tax Payment	Director, CEO CFO	FTax Payment	−607 sh	$4.76	−$2,889.32	13,472
2024-05-28	PALIPALISADE BIO, INC.F Tax Payment	Director, CEO CFO	FTax Payment	−959 sh	$4.76	−$4,564.84	11,968
2024-05-24	PALIPALISADE BIO, INC.P Purchase	Director, CEO CFO	PPurchase	+1,000 sh	$4.81	+$4,810	8,437
2024-05-20	PALIPALISADE BIO, INC.A Award	Director, CEO CFO	AAward	+666 sh	$4.97	+$3,311.685	7,437
2024-05-06	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−211 sh	—	—	2,111
2024-05-06	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−232 sh	—	—	1,622
2024-05-06	PALIPALISADE BIO, INC.F Tax Payment	Director, CEO CFO	FTax Payment	−61 sh	$8.46	−$516.06	6,771
2024-05-06	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+211 sh	—	—	6,832
2024-05-06	PALIPALISADE BIO, INC.F Tax Payment	Director, CEO CFO	FTax Payment	−67 sh	$8.46	−$566.82	6,621
2024-05-06	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+232 sh	—	—	6,688
2024-03-11	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+5,558 sh	—	—	96,849
2024-03-11	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−5,558 sh	—	—	50,025
2024-02-06	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−3,167 sh	—	—	34,833
2024-02-06	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−3,475 sh	—	—	27,800
2024-02-06	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+3,167 sh	—	—	91,291
2024-02-06	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+3,475 sh	—	—	88,124
2024-02-06	PALIPALISADE BIO, INC.P Purchase	Director, CEO CFO	PPurchase	+10K sh	$0.47	+$4,692	84,649
2024-01-31	PALIPALISADE BIO, INC.P Purchase	Director, CEO CFO	PPurchase	+10K sh	$0.56	+$5,590	74,649
2024-01-03	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−1,309 sh	—	—	0
2024-01-03	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+1,309 sh	—	—	64,649
2023-12-11	PALIPALISADE BIO, INC.M Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	+5,559 sh	—	—	63,340
2023-12-11	PALIPALISADE BIO, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, CEO CFO	MExercise/Conversion	−5,559 sh	—	—	55,583
2023-11-21	PALIPALISADE BIO, INC. · Common Stock OptionsA Award	Director, CEO CFO	AAward	+45K sh	—	—	45,000
2023-11-21	PALIPALISADE BIO, INC. · Restricted Stock UnitsA Award	Director, CEO CFO	AAward	+38K sh	—	—	38,000

Recent filings

Accepted (ET)
Oct 74
Finley John David0001493152-26-046201
SEC(opens sec.gov)
Aug 214
Finley John David0001493152-26-039746
SEC(opens sec.gov)
Jul 84
Finley John David0001493152-26-032559
SEC(opens sec.gov)
Feb 134
Finley John David0001493152-26-006831
SEC(opens sec.gov)
Feb 114
Finley John David0001493152-26-006255
SEC(opens sec.gov)
Oct 84
Finley John David0001493152-25-017475
SEC(opens sec.gov)
Sep 54
Finley John David0001493152-25-012690
SEC(opens sec.gov)
Feb 134
Finley John David0001493152-25-006498
SEC(opens sec.gov)
May 304
Finley John David0001493152-24-022037
SEC(opens sec.gov)

Companies

PALISADE BIO, INC.Director, CEO CFOPALI

Address

C/O PALISADE BIO, INC. 4600 SOUTH SYRACUSE STREET, SUITE 900

DENVER, CO, 80237